V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002675 | 210008490 | 1.72 | 57 | Palliative (P) | 2016-08-23 | 2016-10-24 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101286413 |
| 210002676 | 210008491 | null | 105.5 | Palliative (P) | 2021-04-13 | 2021-06-22 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101080226 |
| 210002677 | 210008492 | 1.68 | 68.3 | Adjuvant (A) | 2017-12-07 | 2017-12-09 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 100072849 |
| 210002679 | 210008494 | null | null | Palliative (P) | 2020-03-06 | 2020-03-30 | Docetaxel | N | null | DOCETAXEL | 101145468 |
| 210002685 | 210008496 | 1.66 | 72.3 | Palliative (P) | 2016-05-22 | 2016-07-31 | Trastuzumab | N | N | TRASTUZUMAB | 101105243 |
| 210002688 | 210008498 | 1.74 | 89 | null | 2019-11-28 | 2019-12-17 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100802577 |
| 210002689 | 210008499 | 1.68 | 77.1 | Adjuvant (A) | 2018-12-10 | 2020-07-04 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101447983 |
| 210002690 | 210008500 | 1.68 | null | Curative (C) | 2018-12-16 | 2019-03-04 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101000028 |
| 210002691 | 210008501 | 1.6 | 49.8 | Adjuvant (A) | 2019-10-13 | 2019-10-20 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101118760 |
| 210002694 | 210008502 | null | null | Palliative (P) | 2018-10-17 | 2018-10-22 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100885288 |
| 210002695 | 210008503 | 1.64 | 0 | null | 2020-04-27 | 2020-05-07 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100147319 |
| 210002696 | 210008504 | 1.63 | 68.7 | Palliative (P) | 2019-03-16 | 2019-03-17 | Docetaxel | 02 | N | DOCETAXEL | 100348719 |
| 210002698 | 210008506 | 1.63 | 70 | null | null | 2020-09-29 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100824686 |
| 210002700 | 210008508 | 1.58 | 70.9 | Palliative (P) | null | 2018-12-08 | Docetaxel | 02 | N | DOCETAXEL | 101101719 |
| 210002701 | 210008509 | 1.58 | null | Palliative (P) | 2018-10-26 | 2018-11-09 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100082008 |
| 210002702 | 210008510 | 1.58 | 86.2 | Adjuvant (A) | 2015-09-20 | 2016-09-22 | Docetaxel 100mg/m2 (21 day) | N | N | DOCETAXEL | 101459210 |
| 210002707 | 210008512 | 1.53 | 65 | Adjuvant (A) | null | 2018-06-01 | Trastuzumab | 02 | N | TRASTUZUMAB | 101354051 |
| 210002709 | 210008513 | 1.64 | 59.8 | Adjuvant (A) | 2020-08-24 | 2020-11-11 | Paclitaxel (2 or 3 weekly) | 02 | N | PACLITAXEL | 100935404 |
| 210002710 | 210008514 | 1.61 | 54.7 | Palliative (P) | null | 2019-08-10 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101852422 |
| 210002711 | 210008515 | null | 52.8 | null | 2016-06-01 | 2016-06-29 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100873272 |
| 210002712 | 210008516 | 1.65 | 86.2 | null | 2017-04-24 | 2017-04-30 | Docetaxel | 02 | N | DOCETAXEL | 101256053 |
| 210002713 | 210008517 | 1.67 | 91 | Adjuvant (A) | 2017-07-14 | 2017-08-18 | Docetaxel | 02 | N | DOCETAXEL | 100963064 |
| 210002716 | 210008519 | 1.45 | 62 | null | 2016-08-24 | 2016-09-02 | Trastuzumab 21 day loading dose | 02 | null | TRASTUZUMAB | 101582032 |
| 210002718 | 210008521 | 1.62 | 86.5 | Palliative (P) | 2016-08-13 | 2016-11-26 | EC | N | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100031869 |
| 210002720 | 210008523 | null | 75.5 | null | null | 2018-03-21 | Paclitaxel 7 day | N | null | PACLITAXEL | 101736344 |
| 210002722 | 210008524 | 1.96 | 57 | Adjuvant (A) | 2016-07-01 | 2016-07-30 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101558458 |
| 210002725 | 210008525 | null | null | null | null | 2020-10-23 | PACLITAXEL | null | null | PACLITAXEL | 100897893 |
| 210002726 | 210008526 | 1.65 | 86.3 | Palliative (P) | 2017-01-31 | 2017-01-31 | EC | 02 | Y | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100496962 |
| 210002728 | 210008528 | 1.66 | 88 | Adjuvant (A) | 2016-07-13 | 2016-07-26 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101046182 |
| 210002730 | 210008530 | 1.57 | 78.9 | Adjuvant (A) | 2018-02-05 | 2019-01-17 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 101276214 |
| 210002731 | 210008531 | 1.58 | 61.6 | Curative (C) | null | 2020-04-26 | Docetaxel 100mg/m2 (21 day) | null | null | DOCETAXEL | 100380953 |
| 210002734 | 210008533 | 1.51 | 96 | Adjuvant (A) | 2018-09-26 | 2018-12-18 | Docetaxel 100mg/m2 (21 day) | 01 | N | DOCETAXEL | 101390420 |
| 210002736 | 210008534 | 1.73 | 54.1 | Adjuvant (A) | 2017-02-04 | 2017-02-05 | Trastuzumab | null | N | TRASTUZUMAB | 101364491 |
| 210002737 | 210008535 | 1.55 | 74 | Neo-adjuvant (N) | 2018-05-29 | 2018-06-18 | Paclitaxel 7 day | 01 | null | PACLITAXEL | 100852551 |
| 210002738 | 210008536 | 1.72 | 64.8 | Neo-adjuvant (N) | 2021-08-19 | 2021-09-09 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101669347 |
| 210002740 | 210008537 | 1.75 | 68 | Palliative (P) | 2017-12-27 | 2019-12-04 | PACLITAXEL | N | null | PACLITAXEL | 101734692 |
| 210002746 | 210008541 | 1.56 | 106 | Adjuvant (A) | null | 2017-04-11 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101764552 |
| 210002748 | 210008542 | 1.66 | 64 | Adjuvant (A) | 2016-06-13 | 2016-06-26 | Paclitaxel 7 day | null | N | PACLITAXEL | 100649391 |
| 210002753 | 210008545 | 1.5 | 89 | Adjuvant (A) | 2016-09-13 | 2016-10-26 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101849442 |
| 210002755 | 210008547 | 1.7 | 64 | null | 2022-03-30 | 2022-04-14 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100776013 |
| 210002756 | 210008548 | 1.72 | 112 | Adjuvant (A) | null | 2020-06-18 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100142963 |
| 210002757 | 210008549 | 1.62 | 98.6 | Adjuvant (A) | 2016-09-18 | 2016-09-19 | Docetaxel | 02 | N | DOCETAXEL | 101755554 |
| 210002760 | 210008552 | 1.47 | 86 | Adjuvant (A) | null | 2018-10-12 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101454782 |
| 210002761 | 210008553 | 1.56 | 58.5 | Adjuvant (A) | 2016-06-22 | 2016-11-16 | Docetaxel | N | N | DOCETAXEL | 100837925 |
| 210002762 | 210008554 | 1.65 | 90 | Palliative (P) | 2018-08-09 | 2018-11-01 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100426535 |
| 210002763 | 210008555 | 1.5 | 63.7 | Palliative (P) | null | 2014-02-17 | PACLITAXEL | null | N | PACLITAXEL | 100078713 |
| 210002764 | 210008556 | 1.57 | 111 | Adjuvant (A) | null | 2019-03-21 | PACLITAXEL | 02 | N | PACLITAXEL | 100270661 |
| 210002770 | 210008561 | 1.73 | 75 | Neo-adjuvant (N) | 2016-02-15 | 2017-08-05 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100655903 |
| 210002773 | 210008562 | 0 | null | Not known (9) | 2017-06-10 | 2017-07-23 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100097853 |
| 210002774 | 210008563 | 1.96 | 81.2 | Palliative (P) | null | 2019-01-06 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100800687 |